🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
3,187
Companies
1,062
Pipeline programs
18,156

Quick answer

NovaPharmaNews tracks 3,187 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 68 of 133 · A–Z by INN

  1. ketorolac tromethamine

    ACULAR LS Amphastar France Pharmaceuticals

    NASAL approved

  2. ketotifen fumarate

    KETOTIFEN FUMARATE Essential Pharma Limited

    OPHTHALMIC approved

  3. krypton, kr-81m

    MPI KRYPTON 81M GENERATOR

    INHALATION approved

  4. l-acetylleucine

    AQNEURSA

    N07XX27

  5. l-glutamine

    ENDARI

    ORAL approved

  6. labetalol hydrochloride

    TRANDATE Amneal Pharma Europe Ltd

    INJECTION approved

  7. lacosamide

    LACOSAMIDE PAIN UCB PHARMA Amneal Pharma Europe Ltd

    ORAL approved

    N03AX18

  8. lactitol

    PIZENSY

    ORAL approved

  9. lactulose

    GENERLAC Teva Pharma GmbH

    ORAL, RECTAL approved

  10. lamivudine

    COMBIVIR Teva Pharma GmbH

    ORAL approved

    J05AF05

  11. lamivudine, nevirapine, and stavudine

    LAMIVUDINE, NEVIRAPINE, AND STAVUDINE

    ORAL approved

  12. lamotrigine

    LAMOTRIGINE Amneal Pharma Europe Ltd

    ORAL approved

  13. lanadelumab

    TAKHZYRO Takeda Pharmaceuticals International AG

    B06AC05

  14. lanadelumab-flyo

    TAKHZYRO

    SUBCUTANEOUS approved

  15. landiolol hydrochloride

    RAPIBLYK

    INTRAVENOUS approved

  16. lanreotide acetate

    SOMATULINE DEPOT

    SUBCUTANEOUS approved

  17. lansoprazole

    LANSOPRAZOLE Takeda Pharmaceuticals International AG

    ORAL approved

  18. lanthanum carbonate

    LANTHANUM CARBONATE Takeda Pharmaceuticals International AG

    ORAL approved

  19. lapatinib

    TYVERB

    L01EH01

  20. lapatinib ditosylate

    LAPATINIB DITOSYLATE Teva Pharma GmbH

    ORAL approved

  21. lapyrium chloride

    VIRAC REX

    TOPICAL approved

  22. laronidase

    ALDURAZYME BioMarin International Limited

    approved

    A16AB05

  23. larotrectinib

    VITRAKVI

    L01XE53

  24. larotrectinib sulfate

    VITRAKVI

    ORAL approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,187 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources